Simeon George, Director at Turning Point Therapeutics, Inc. (TPTX), bought 83,333 shares at $60.00 ($5.0M) on 2020-05-21, disclosed to the SEC on 2020-05-26.
Open-market purchase of $5.0M TPTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| DSGN | BUY | 2022-12-20 | $14.8M | — | Filing → |
| NKTX | BUY | 2022-04-29 | $20.0M | — | Filing → |
| DSGN | BUY | 2021-04-01 | $5.0M | — | Filing → |